Drew Meyer is a Special Counsel in the Firm’s Seattle office and a member of the Health Care practice group. For over 10 years, he has led corporate investigations involving the Foreign Corrupt Practices Act (“FCPA”), False Claims Act (qui tam suits), and Anti-Kickback Statute. He possesses extensive experience in communicating with whistleblowers, conducing investigative interviews, and counseling client stakeholders on mitigation and remediation strategies resulting from investigations.

Mr. Meyer served as Global Investigations Director at Takeda Pharmaceuticals, where he was responsible for the Americas region, and as the Global Investigations Lead at UCB Pharmaceuticals with global remit. Drew also spent five years in China working for an investigations and crisis management consulting firm, where he led consulting teams in the provision of investigation services to life sciences companies in the areas of financial and accounting fraud, handling Code of Conduct violations, advising business compliance committees, and crisis management and response. Most recently, Drew worked at Paul Hastings as a consultant in the Life Sciences Consulting Group.

Mr. Meyer began his career in the Federal Bureau of Investigation, focusing on counterintelligence issues. He speaks and reads Mandarin Chinese at a professional level.